HIGHLIGHTS
- who: Hirokazu Taniguchi and collaborators from the Japan, Faculty of Agriculture, Ryukoku, Shiga, Japan, Division of PreventiveEditor: Tomislav Bulum, Medical School, University have published the research work: Association of serum fibroblast growth factor 21 with diabetic complications and insulin dose in patients with type 1 diabetes mellitus, in the Journal: PLOS ONE
- what: This study examined the determinant factors of circulating FGF21 concentration in middle-aged and elderly patients with T1DM. It has been considered that reduced FGF21 secretion impairs glycemic control in T1DM patients; hence, this study compared metabolic differences between T1DM patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.